Shingo Nakamoto

Sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Japan

Sadahisa Ogasawara, Yoshihiko Ooka, Norio Itokawa et al. · Investigational New Drugs · 2019 · 82 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Potential of Lenvatinib for an Expanded Indication from the REFLECT Trial in Patients with Advanced Hepatocellular Carcinoma

Susumu Maruta, Sadahisa Ogasawara, Yoshihiko Ooka et al. · Liver Cancer · 2020 · 80 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Chromoendoscopy with indigo carmine dye added to acetic acid in the diagnosis of gastric neoplasia: a prospective comparative study

Yuzo Sakai, Reiko Eto, Junji Kasanuki et al. · Gastrointestinal Endoscopy · 2008 · 79 citations

Medicine, Clinical Sciences, Oncology +14

Characteristics of patients with sorafenib-treated advanced hepatocellular carcinoma eligible for second-line treatment

Sadahisa Ogasawara, Tetsuhiro Chiba, Yoshihiko Ooka et al. · Investigational New Drugs · 2017 · 68 citations

Medicine, Oncology, Pharmacotherapy +11

Association between mutations in the core region of hepatitis C virus genotype 1 and hepatocellular carcinoma development

Shingo Nakamoto, Fumio Imazeki, Kenichi Fukai et al. · Journal of Hepatology · 2009 · 58 citations

Life Sciences, Genetics, Molecular Genetics +16